About The Study: The results of this meta-analysis of 286 randomized clinical trials including 9,500 patients suggest that Black and Hispanic men are underrepresented in trials compared with their share of prostate cancer incidence. The representation of Black patients has consistently remained low during the past 2 decades.
Authors: Irbaz Bin Riaz, M.B.B.S., M.S., of Harvard Medical School in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2022.5511)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5511?guestAccessKey=f799505c-99e1-4b63-a9b1-95df0244791e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112322
JAMA Oncology